Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast Cancer
Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast Cancer
Active, not recruiting · NCT01251874 · Registry updated 2026-05-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Active, not recruiting | Phase 1 | 2026-05-22 | NCT01251874 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Montefiore Medical Center - Moses Campus | The Bronx | United States | 219 |
| Montefiore Medical Center-Einstein Campus | The Bronx | United States | 170 |
| Ohio State University Comprehensive Cancer Center | Columbus | United States | 548 |